A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Relamorelin (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Acronyms MOVE-PD
- Sponsors Rhythm
- 14 Oct 2015 Planned End Date changed from 1 Jul 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
- 14 Oct 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 10 Jun 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.